Elevation Oncology Stock Forecast - Simple Regression

ELEVDelisted Stock  USD 0.37  0.00  0.00%   
The Simple Regression forecasted value of Elevation Oncology on the next trading day is expected to be 0.38 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.23. Elevation Stock Forecast is based on your current time horizon.
  
Simple Regression model is a single variable regression model that attempts to put a straight line through Elevation Oncology price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Elevation Oncology Simple Regression Price Forecast For the 28th of July

Given 90 days horizon, the Simple Regression forecasted value of Elevation Oncology on the next trading day is expected to be 0.38 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0006, and the sum of the absolute errors of 1.23.
Please note that although there have been many attempts to predict Elevation Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Elevation Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Elevation Oncology Stock Forecast Pattern

Backtest Elevation OncologyElevation Oncology Price PredictionBuy or Sell Advice 

Elevation Oncology Forecasted Value

In the context of forecasting Elevation Oncology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Elevation Oncology's downside and upside margins for the forecasting period are 0 and 5.49, respectively. We have considered Elevation Oncology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.37
0.38
Expected Value
5.49
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Elevation Oncology stock data series using in forecasting. Note that when a statistical model is used to represent Elevation Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria110.771
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0202
MAPEMean absolute percentage error0.0599
SAESum of the absolute errors1.2335
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Elevation Oncology historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Elevation Oncology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elevation Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elevation Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.375.48
Details
Intrinsic
Valuation
LowRealHigh
0.010.305.41
Details

Other Forecasting Options for Elevation Oncology

For every potential investor in Elevation, whether a beginner or expert, Elevation Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Elevation Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Elevation. Basic forecasting techniques help filter out the noise by identifying Elevation Oncology's price trends.

Elevation Oncology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elevation Oncology stock to make a market-neutral strategy. Peer analysis of Elevation Oncology could also be used in its relative valuation, which is a method of valuing Elevation Oncology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Elevation Oncology Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Elevation Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Elevation Oncology's current price.

Elevation Oncology Market Strength Events

Market strength indicators help investors to evaluate how Elevation Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Elevation Oncology shares will generate the highest return on investment. By undertsting and applying Elevation Oncology stock market strength indicators, traders can identify Elevation Oncology entry and exit signals to maximize returns.

Elevation Oncology Risk Indicators

The analysis of Elevation Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Elevation Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting elevation stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Historical Fundamental Analysis of Elevation Oncology to cross-verify your projections.
You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Elevation Stock

If you are still planning to invest in Elevation Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elevation Oncology's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios